Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001225208-19-004340)

Filing Details

Accession Number:
0001225208-19-004340
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-04 16:29:41
Reporting Period:
2019-03-01
Accepted Time:
2019-03-04 16:29:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885725 Boston Scientific Corp BSX Surgical & Medical Instruments & Apparatus (3841) 042695240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1566080 J. Kevin Ballinger 300 Boston Scientific Way
Marlborough MA 01752-1234		 Evp & Pres, Interven Cardio No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-03-01 20,900 $40.74 77,572 No 4 S Direct
Common Stock Acquisiton 2019-03-03 3,302 $0.00 80,874 No 4 M Direct
Common Stock Disposition 2019-03-03 1,506 $40.75 79,368 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 F Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Deferred Stock Units Disposition 2019-03-03 3,302 $0.00 3,302 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,909 2022-03-03 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
  2. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $40.74 to $40.76, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
  4. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  5. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on March 3, 2018, the first anniversary of the date of grant.